FY2025 Earnings Forecast for aTyr Pharma, Inc. Issued By HC Wainwright (NASDAQ:LIFE)

aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) – Equities researchers at HC Wainwright boosted their FY2025 earnings estimates for aTyr Pharma in a report released on Thursday, September 21st. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn ($0.93) per share for the year, up from their prior forecast of ($0.99). […]

Related Keywords

United States ,Piper Sandler ,Atyr Pharma Inc ,Charles Schwab Investment Management Inc ,A Davidson ,Nasdaq ,Da Davidson ,Squarepoint Ops ,Sigma Securities ,Tyr Pharma ,Free Report ,Get Free Report ,Tyr Pharma Stock ,Street Group ,Charles Schwab Investment Management ,Schwab Investment Management ,Tyr Pharma Daily ,Atyr Pharma ,Nasdaq Life ,Life ,Medical ,53217v10 ,Earnings Estimates ,Hc Wainwright ,